Literature DB >> 31496597

Retrospective Audit of Various Surgical Modalities Adopted for Giant Cell Tumor in a Rural Tertiary Cancer Center.

Basavaraj Ankalkoti1, B Satheesan1, J Dipin1, P Nizamudheen1, N Sangeetha2.   

Abstract

Giant cell tumor of bone (GCTB) is a rare tumor with a spectrum of clinical behavior. Standard treatment modalities include surgical curettage to wide resection, and varying oncological and functional results have been reported. The aim of this study was to evaluate the functional outcome and recurrence rates of patients who underwent surgery for giant cell tumor in a rural tertiary cancer center from June 2009 to December 2016. A retrospective review of 12 patients (7 males and 5 females) with GCT of the extremity bones treated in the institution between the period of June 2009 and December 2016 was performed to study the oncological and functional outcomes. All patients were evaluated by clinical examination, plain X-ray of local parts, X-ray of the chest, and MRI of local parts. A biopsy was taken in all cases to confirm the diagnosis. All patients underwent surgical treatment including curettage combined with cryosurgery and bone cement or wide resection and reconstruction. Selection of the surgical technique was based on the site and size of the lesion, soft tissue involvement (intra- or extra-compartmental), and if recurrent or not. The patients were followed up to April 2018. The mean age of the patients was 31.3 years. The tumor sites were distal femur in 3 cases, proximal tibia in 6, ischial bone in 1, distal radius in 1, and 1 in the metacarpal bone. Campanacci radiographic grading was grade1 in 3 cases, grade 2 in 2 cases, and grade 3 in 7 cases. Out of 12 patients, local recurrence was noted in 2 patients (16.7%). Functional evaluation was performed according to the Musculoskeletal Tumor Society Scoring (MSTS) system. Mean MSTS score was 25. To preserve the good function of the extremities and avoid local recurrence, we consider that curettage with adjunctive therapy such as polymethylmethacrylate (PMMA) and liquid nitrogen should be employed for the treatment of benign GCT of bone. Wide excision should be considered for large tumors where achieving oncological results with functional preservation would be difficult with curettage procedure.

Entities:  

Keywords:  Extended curettage; Giant cell tumor of bone; Musculoskeletal Tumor Society Scoring (MSTS) system

Year:  2019        PMID: 31496597      PMCID: PMC6707980          DOI: 10.1007/s13193-019-00926-5

Source DB:  PubMed          Journal:  Indian J Surg Oncol        ISSN: 0975-7651


  20 in total

Review 1.  Giant cell tumor of bone.

Authors:  Robert E Turcotte
Journal:  Orthop Clin North Am       Date:  2006-01       Impact factor: 2.472

2.  Benign giant-cell tumor of bone with pulmonary metastases: clinical findings and radiologic appearance of metastases in 13 cases.

Authors:  W S Tubbs; L R Brown; J W Beabout; M G Rock; K K Unni
Journal:  AJR Am J Roentgenol       Date:  1992-02       Impact factor: 3.959

3.  Oncologic and functional results after treatment of giant cell tumors of bone.

Authors:  Harm W Boons; Lucien C M Keijser; H W Bart Schreuder; Maciej Pruszczynski; J Albert M Lemmens; René P H Veth
Journal:  Arch Orthop Trauma Surg       Date:  2002-02       Impact factor: 3.067

4.  Radiation therapy in the treatment of difficult giant cell tumors.

Authors:  L H Schwartz; P G Okunieff; A Rosenberg; H D Suit
Journal:  Int J Radiat Oncol Biol Phys       Date:  1989-11       Impact factor: 7.038

Review 5.  Cryosurgery in the treatment of giant cell tumor. A long-term followup study.

Authors:  M M Malawer; J Bickels; I Meller; R G Buch; R M Henshaw; Y Kollender
Journal:  Clin Orthop Relat Res       Date:  1999-02       Impact factor: 4.176

Review 6.  Radiation therapy for giant cell tumor of bone.

Authors:  C J Bennett; R B Marcus; R R Million; W F Enneking
Journal:  Int J Radiat Oncol Biol Phys       Date:  1993-05-20       Impact factor: 7.038

7.  [Giant cell tumor of bone. An evaluation of 87 patients].

Authors:  P-U Tunn; P M Schlag
Journal:  Z Orthop Ihre Grenzgeb       Date:  2003 Nov-Dec

8.  Total sacrectomy and reconstruction for sacral tumors.

Authors:  Minoru Doita; Toshihiko Harada; Tetsuhiro Iguchi; Masatoshi Sumi; Hidenori Sha; Shinichi Yoshiya; Masahiro Kurosaka
Journal:  Spine (Phila Pa 1976)       Date:  2003-08-01       Impact factor: 3.468

Review 9.  Recurrence of giant-cell tumors of the long bones after curettage and packing with cement.

Authors:  R J O'Donnell; D S Springfield; H K Motwani; J E Ready; M C Gebhardt; H J Mankin
Journal:  J Bone Joint Surg Am       Date:  1994-12       Impact factor: 5.284

10.  Giant cell tumour of bone. A surgical approach to grade III tumours.

Authors:  R J Rooney; R Asirvatham; R M Lifeso; M A Ali; S Parikh
Journal:  Int Orthop       Date:  1993       Impact factor: 3.075

View more
  1 in total

Review 1.  Global Prevalence and Risk of Local Recurrence Following Cryosurgery of Giant Cell Tumour of Bone: A Meta-Analysis.

Authors:  Shyful Nizam Sumari; Nor Azman Mat Zin; Wan Faisham Wan Ismail; Md Asiful Islam
Journal:  Cancers (Basel)       Date:  2022-07-08       Impact factor: 6.575

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.